Pharma Equity Group A/S Cl A (PEG) — Cash Flow Quality Index
Pharma Equity Group A/S Cl A (PEG) has a Cash Flow Quality Index of 0.36x as of December 2022. Operating cash flow of Dkr4.24 Million is below net income of Dkr11.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PEG operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Equity Group A/S Cl A Cash Flow Quality Index (2017–2022)
Historical Cash Flow Quality Index for Pharma Equity Group A/S Cl A across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Pharma Equity Group A/S Cl A generate cash.
Annual Cash Flow Quality Index for Pharma Equity Group A/S Cl A (2017–2022)
Year-by-year earnings quality comparison for Pharma Equity Group A/S Cl A.
| Year | Quality Index | Operating CF (DKK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.83x | Dkr-2.87 Million | Dkr3.48 Million | ▼ -113.2% |
| 2021 | -0.39x | Dkr-2.09 Million | Dkr5.39 Million | ▲ +98.6% |
| 2017 | -27.80x | Dkr-4.92 Million | Dkr177.00K | — |